SPECIAL NOTICE
A -- Genetic Characterization of HIV-1 Strains from Cameroon and Their Implication in HIV Diagnosis
- Notice Date
- 5/21/2009
- Notice Type
- Special Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA1055752
- Archive Date
- 6/20/2009
- Point of Contact
- David - Kordel,
- E-Mail Address
-
david.kordel@fda.hhs.gov
(david.kordel@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- The Food and Drug Administration, Office of Acquisition and Grants Services intends to award a non-competitive purchase order to the New York University, located at 70 Washington Square S, New York, NY 10012-1019, to continue research and consulting services on HIV Aids & sample collection in Cameroon. The NAICS code for this requirement is 541711 - Research and Development in Biotechnology. In accordance with 41 U.S.C. 2539 (c)(1), other than full and open competition, only one (1) responsible source and no other supplies or services satisfy the Agency’s requirements, services are being procured pursuant to FAR 6.302-1(a)(2)(1). Contractor’s responsibilities include research, identify and prepare surveillance of different HIV-1 subtype strains infecting blood donors. To identify aberrant HIV-1 viruses in plasma samples from subjects suspect of HIV-infection. Investigate the viral diversity of HIV among blood donor and the general population in Cameroon. Evaluate the impact of HIV diversity on the performance of diagnostic and donor screening assays. This firm is the only known Contractor within the US & Cameroon with the demonstrated ability to provide the requested services within the time period. In addition, this contractor has successfully completed same or similar work in the past. Period of Performance: base year: 15 June 2009 through 14 June 2010 plus two option years. This Public Notice of Intent is NOT a request for competitive price quotations or proposals. However, other interested individuals or firms may express to the U.S. Government their interest in and submit clearly detailed documentation to perform the above study to research, identify and prepare surveillance of different HIV-1 subtype strains infecting blood donors in Cameroon. The documentation shall be sufficient in detail to allow an evaluation without the need for additional information. Any such written expressions of interest AND accompanying detailed written statements must be received by the Government Contract Specialist by 5 June 2009 at 4:30 P.M. Eastern Standard Time and shall reference number FDA1055752. The Government will not accept oral or incomplete submissions. A final determination by the Government not to compete this proposed procurement, based upon any responses to this Public Notice, is solely within the discretion of the Government. Any information received from interested persons or firms responding to this Public Notice will be considered by the Government solely for the purpose of determining whether to conduct a competitive procurement. Any submissions regarding this Public Notice shall be in writing to the Government Contract Specialist, David Kordel, via E-mail at david.kordel@fda.hhs.gov. This Public Notice is not a RFQ, RFP, or IFB.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA1055752/listing.html)
- Record
- SN01825512-W 20090523/090522000151-9aa504347f43f237262920457ca1479c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |